Last year’s M&A and licensing figures suggest that there is a sellers' market in many types of life sciences assets
IAM's annual IP benchmarking survey opens today
IAM is currently seeking nominations for individuals to be considered for the 2020 edition of the Strategy 300 - our unique guide to the men and women who excel in the creation of IP value
Exact terms remain confidential, but TSMC's CEO suggested to employees that the licence rights are not transferrable should Globalfoundries be acquired
Shenzhen Transsion, the dominant mobile phone seller on the African continent, said to have come into IP conflict with Huawei shortly before going public
TSMC is the target and nineteen other tech firms are in the crossfire. Here are the takeaways from a big chip sector dispute that’s taking on a trade war tinge
Special IAM boardroom session at IPBC Global 2019 focuses on how to get more women involved in senior positions in the global IP market - and why everyone will win when it happens
Shenzhen-based Transsion is a dominant market player in Africa, but a light IP portfolio might complicate its ambitious expansion plans
Patent focus has shifted to energy storage as cost-effectiveness achieved for wind and solar power, but the failure to address the role of IP hinders transfer mechanisms
IAM's annual benchmarking survey is designed to identify the key concerns of senior decision makers in areas such as deal-making, valuation, patent office performance, top litigation venues and policy
The Korean electronics giant has bought Corephotonics, an Israeli startup that is taking on Apple in Judge Lucy Koh’s Northern District of California courtroom
New IAM research reports identify the key trends shaping the global IP market – and tell you how to respond
Corephotonics, a developer of dual camera technologies based in Tel Aviv, last week announced a licensing agreement with Chinese smartphone maker Oppo. It appears to be the first publicly announced IP licence with a major smartphone OEM for the…
While the global quarrel over the pricing of patented drugs continues unabated, Swiss pharmaceutical giant Novartis has announced that it will offer a number of its medicines at significant discount to developing countries. According to a press…
IPBC Global in San Francisco is now finished, but only after another compelling day of sessions, networking and discussion. Here, IAM’s editorial team – Joff Wild, Richard Lloyd, Jack Ellis and Sara Jayne Clover – pick out a few of the highlights: …
